People · Operator
Named in public records as an officer, director or promoter · active 2009–2012 · Biotechnology, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Link Medicine Corp | — | Biotechnology | Series B | $64.8M | $190.8M | 2010 |
| Verenium Corp | — | Other Energy | Series A | $33.8M | $77.3M | 2009 |
John F. Dee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John F. Dee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Ross | 1 | 18 |
| Peter Johnson | 1 | 11 |
| David Guyer | 1 | 8 |
| David Neafus | 1 | 7 |
| Joshua Ruch | 1 | 7 |
| Jeffrey G. Black | 1 | 3 |
| Nick Galakatos | 1 | 3 |
| James H. Cavanaugh | 1 | 2 |
| William H. Baum | 1 | 2 |
| Joshua F. Ruch | 1 | 2 |
| Adam J. Rosenberg | 1 | 2 |
| Michael Zak | 1 | 2 |
| Scott Young | 1 | 2 |
| Gerald M Haines | 1 | 2 |
| Alexander A. Fitzpatrick | 1 | 2 |
| Jeffrey A Black | 1 | 1 |
| Peter F. Johnson | 1 | 1 |
| Janet Roemer | 1 | 1 |
| James Levine | 1 | 1 |
| Michael F. Zak | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.